Xiao Yu-Feng, He Jia-Lin, Xu Yu, Liu Xi, Lin Hui, Li Qi, Xu Zhi, Hu Ming-Dong, Ren Xiao-Bao, Zhang Cheng, Zhang Wen-Jing, Duan Wei, Tian Yong-Feng, Li Ping, Wu Hao, Song Cai-Ping, Liu En, Yang Shi-Ming
Department of Gastroenterology, Xinqiao Hospital, The Army Medical University, Chongqing, China.
Huo-Shen-Shan Hospital, Wuhan, China.
Front Med (Lausanne). 2021 Jun 7;8:655604. doi: 10.3389/fmed.2021.655604. eCollection 2021.
Diabetes is a risk factor for poor COVID-19 prognosis. The analysis of related prognostic factors in diabetic patients with COVID-19 would be helpful for further treatment of such patients. This retrospective study involved 3623 patients with COVID-19 (325 with diabetes). Clinical characteristics and laboratory tests were collected and compared between the diabetic group and the non-diabetic group. Binary logistic regression analysis was applied to explore risk factors associated in diabetic patients with COVID-19. A prediction model was built based on these risk factors. The risk factors for higher mortality in diabetic patients with COVID-19 were dyspnea, lung disease, cardiovascular diseases, neutrophil, PLT count, and CKMB. Similarly, dyspnea, cardiovascular diseases, neutrophil, PLT count, and CKMB were risk factors related to the severity of diabetes with COVID-19. Based on these factors, a risk score was built to predict the severity of disease in diabetic patients with COVID-19. Patients with a score of 7 or higher had an odds ratio of 7.616. Dyspnea is a critical clinical manifestation that is closely related to the severity of disease in diabetic patients with COVID-19. Attention should also be paid to the neutrophil, PLT count and CKMB levels after admission.
糖尿病是新型冠状病毒肺炎(COVID-19)预后不良的一个危险因素。分析COVID-19糖尿病患者的相关预后因素将有助于对此类患者进行进一步治疗。这项回顾性研究纳入了3623例COVID-19患者(其中325例患有糖尿病)。收集了糖尿病组和非糖尿病组的临床特征及实验室检查结果并进行比较。采用二元逻辑回归分析来探究COVID-19糖尿病患者的相关危险因素。基于这些危险因素建立了一个预测模型。COVID-19糖尿病患者死亡率较高的危险因素包括呼吸困难、肺部疾病、心血管疾病、中性粒细胞、血小板计数和肌酸激酶同工酶(CKMB)。同样,呼吸困难、心血管疾病、中性粒细胞、血小板计数和CKMB是与COVID-19糖尿病严重程度相关的危险因素。基于这些因素,构建了一个风险评分来预测COVID-19糖尿病患者的疾病严重程度。评分7分及以上的患者优势比为7.616。呼吸困难是一种关键的临床表现,与COVID-19糖尿病患者的疾病严重程度密切相关。入院后还应关注中性粒细胞、血小板计数和CKMB水平。